. . . . . . . . . . . . . "p(MGI:Lyn) -> p(MGI:Mapk1)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "PP1, a general pharmacologic inhibitor of Src kinases (Fyn and Lyn), completely abrogated p44/42 mapk activation by fibrillar Amyloid beta. The accumulation of phospho p44/42 was greatly reduced in both fibrillar Amyloid beta treated Fyn-/- and Lyn-/- macrophages as compared with wild type cells." . . "Selventa" . . . . "2014-07-03T14:29:52.328+02:00"^^ . . .